In our first episode of 2023 we answer your employee benefits and pharmacy benefit questions. Listen as we cover:
- The latest on rising insulin prices,
- What the launch of a Humira biosimilar means for payors and plan sponsors,
- How employers can combat exorbitant carve-out fees charged by some medical providers,
- The future of rebates,
- What employers can do to protect their pharmacy plan against the high costs of gene therapies,
- The ideal amount of time for a PBM finalist meeting, and
- Our predictions for pharmacy trend in 2023.
In this podcast
Michael Stull, MBA
Employers Health | Chief Sales Officer
As chief sales officer, Mike’s primary focus is on strengthening the Employers Health brand and growing membership, particularly in the coalition’s 25-year, $2.6 billion group purchasing program for pharmacy benefits.
Read More
Emily Clevenger
Employers Health | Director, Marketing
Emily Clevenger is a member of the Employers Health marketing communications team.
Read More